Study Group: Psychiatrists(?)
Council Members in this Study Group: 1442
Request a survey with this Study Group
Leading Experts in this Study Group
Psychiatrist
North Scottsdale Psychiatric Specialists
Robert Schulte, MD, is a Private Practitioner and a Psychiatrist at North Scottsdale Psychiatric Specialists in Arizona. He is board certified in Adult Psychiatry and Child and Adolescent Psychiatry with extensive experience with children and adult's re-psychotherapy and psychopharmacology and the treatment...
Owner
Amit Vijapura, MD
Amit Vijapura, MD, is a Private Practitioner in Psychiatry based in Florida. He has over 15 years of experience in the field and has expertise in depression, bipolar disorder, anxiety disorder, attention deficient disorder, and schizophrenia. Dr. Vijapura is board certified in Psychiatry and is also...
Founder and Director
Institute for Integrative Psychiatry
Rami Kaminski, MD, is Director and Founder of the Institute for Integrative Psychiatry in New York, a not-for-profit organization aimed at evaluating current psychiatric services and how they integrate with medicine, such as the mutual effects between medical and psychiatric conditions. Prior to that,...
President
Red Oak Psychiatry Associates, P. A.
Lawrence Ginsberg, MD, is President and CEO of Red Oak Psychiatry Associates, PA, a multidisciplinary mental health group in Houston, Texas. Dr. Ginsberg's research interests include psychopharmacology, addiction medicine, and forensic psychiatry. His areas of clinical expertise are attention deficit...
Louis Sanfilippo, MDPresident
LCS Group, LLC
Louis Sanfilippo, MD, is President of the LCS Group, since April 2008, a consulting firm focused on pharmaceutical development and market strategy. He is an Assistant Clinical Professor of Psychiatry at Yale School of Medicine and in private practice. Dr. Sanfilippo has served management and scientific...
Related Study Groups
| Study Group Name | Members |
|---|---|
| Psychiatrists (US) | 1105 |
| Physicians who Treat Schizophrenia (US) | 326 |
| Physicians who Treat ADHD (US) | 382 |
| Psychiatrists (EU) | 251 |
| Child and Adolescent Psychiatrists (US) | 179 |
| Mood Disorder Psychiatrists | 159 |
| Physicians who Treat Depression (US) | 365 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
This large study shows that PD patients' severity of motor dysfunction is better on rasagiline than on placebo.
More psychiatrists are doing less exclusively psychotherapy in their practices than in past years. The implication is that there is a relatively higher percentage of psychiatrists who will need to know about the latest development of psychopharmacology . Whereas in the past psychiatrists who were psychoanalysts...
All is not as it seems when reported in the press, especially the non-scientific press.
-Pharmacogenetic tests have not made it into the treatment or assessment process for most physicians. -Until the cost for these tests become negligible -- or, included in the cost of a particular antidepressant -- psychopharmacogenetic testing will not make it into the mainstream.
“Personalized medical diagnositics” looks to be evolving as a high impact area in neuropsychiatric drug development. Such ‘genetic biomarker’ platforms, based on either pharmacogenetic profiles coming from DNA blueprints or gene products from a simple blood draw, aim to identify patients who are...
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Academic Institution*
- Non-Academic Community Hospital or Clinic
- Government/Military Hospital or Clinic
Most Common Job Types:
- Physician - Attending Physician
- Owner
- Physician - Director
- Director
- Professor
- Medical Director
- President
- Physician - Division Head
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms